These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33211137)

  • 21. Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery.
    Fellinger EK; Leavitt BJ; Hebert JC
    Ann Thorac Surg; 2002 Oct; 74(4):1187-90. PubMed ID: 12400766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery under cardiopulmonary bypass.
    Odaka M; Minakata K; Toyokuni H; Yamazaki K; Yonezawa A; Sakata R; Matsubara K
    Gen Thorac Cardiovasc Surg; 2015 Aug; 63(8):446-52. PubMed ID: 25925714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of cefazolin in pediatric patients undergoing cardiac surgery.
    Lapmahapaisan S; Maisat W; Tantiwongkosri K; Jutasompakorn P; Sisan W
    Ann Card Anaesth; 2021; 24(2):149-154. PubMed ID: 33884969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting.
    Shoulders BR; Crow JR; Davis SL; Whitman GJ; Gavin M; Lester L; Barodka V; Dzintars K
    Pharmacotherapy; 2016 Feb; 36(2):166-73. PubMed ID: 26799442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery.
    Alli A; Paruk F; Roger C; Lipman J; Calleemalay D; Wallis SC; Scribante J; Richards GA; Roberts JA
    PLoS One; 2023; 18(9):e0291425. PubMed ID: 37729151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacokinetic framework describing antibiotic adsorption to cardiopulmonary bypass devices.
    O'Hanlon CJ; Holford N; Anderson BJ; Greaves M; Blackburn L; Tingle MD; Hannam JA
    CPT Pharmacometrics Syst Pharmacol; 2024 Aug; 13(8):1409-1421. PubMed ID: 38813588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest.
    Caffarelli AD; Holden JP; Baron EJ; Lemmens HJ; D'Souza H; Yau V; Olcott C; Reitz BA; Miller DC; van der Starre PJ
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1338-43. PubMed ID: 16733167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.
    Grupper M; Kuti JL; Swank ML; Maggio L; Hughes BL; Nicolau DP
    J Clin Pharmacol; 2017 Jun; 57(6):712-719. PubMed ID: 27925657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.
    van Kralingen S; Taks M; Diepstraten J; van de Garde EM; van Dongen EP; Wiezer MJ; van Ramshorst B; Vlaminckx B; Deneer VH; Knibbe CA
    Eur J Clin Pharmacol; 2011 Oct; 67(10):985-92. PubMed ID: 21499760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacious Cefazolin Prophylactic Dose for Morbidly Obese Women Undergoing Bariatric Surgery Based on Evidence from Subcutaneous Microdialysis and Populational Pharmacokinetic Modeling.
    Palma EC; Meinhardt NG; Stein AT; Heineck I; Fischer MI; de Araújo B; Dalla Costa T
    Pharm Res; 2018 Apr; 35(6):116. PubMed ID: 29644481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Blood Product Resuscitation on Cefazolin Pharmacokinetics in Trauma Patients.
    Fouad A; Berry A; Gates J; Kuti JL; Keating JJ
    Surg Infect (Larchmt); 2024 Aug; 25(6):436-443. PubMed ID: 38995850
    [No Abstract]   [Full Text] [Related]  

  • 32. Population pharmacokinetics and pharmacodynamic target attainment analysis of cefazolin using total and unbound serum concentration in patients with prostatectomy or nephrectomy.
    Komatsu T; Kawai Y; Takayama Y; Akamada Y; Kusume E; Ikeda M; Tsumura H; Ishii D; Iwamura M; Okamoto H; Hanaki H; Otori K
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0026724. PubMed ID: 38771029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefazolin concentrations in serum during cardiopulmonary bypass surgery.
    Miglioli PA; Merlo F; Calabrò GB; Allerberger F; Fille M
    Drugs Exp Clin Res; 2005; 31(1):29-33. PubMed ID: 15921027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics and pharmacodynamics of cefazolin using total and unbound serum concentrations in patients with high body weight.
    Chung EK; Cheatham SC; Healy DP; Stock AH; Utley S; Campion M; Murrey T; Gesenhues AM; Jeffery J; Kays MB
    Int J Antimicrob Agents; 2023 Apr; 61(4):106751. PubMed ID: 36758780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic cefazolin concentrations in morbidly obese patients undergoing sleeve gastrectomy: do we achieve targets?
    Grégoire M; Dumont R; Ronchi L; Woillard JB; Atthar V; Letessier E; Cinotti R; Roquilly A; Deslandes G; Jolliet P; Asehnoune K; Dailly E
    Int J Antimicrob Agents; 2018 Jul; 52(1):28-34. PubMed ID: 29501602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship.
    Blum S; Cunha CB; Cunha BA
    Surg Infect (Larchmt); 2019 Sep; 20(6):439-443. PubMed ID: 31112072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
    Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefazolin and netilmicin serum levels during and after cardiac surgery with cardiopulmonary bypass.
    Lehot JJ; Reverdy ME; Etienne J; Corot C; Nervi C; Sear J; Fleurette J; Estanove S
    J Cardiothorac Anesth; 1990 Apr; 4(2):204-9. PubMed ID: 2131868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass.
    Urbánek K; Šantavý P; Zuščich O; Kubíčková V; Michaličková D; Slanař O; Šíma M
    J Chemother; 2023 Nov; 35(7):614-622. PubMed ID: 36715134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of appropriate weight-based cutoffs for empiric cefazolin dosing using data from a phase 1 pharmacokinetics and safety study of cefazolin administered for surgical prophylaxis in pediatric patients aged 10 to 12 years.
    Schmitz ML; Blumer JL; Cetnarowski W; Rubino CM
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4173-80. PubMed ID: 25941220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.